Product Information
LOJAIMIESS 0.1-0.02-0.01 TAB is a generic product labeled by Xiromed LLC, priced at $0.2339 per EA under NDC 70700012487. Its NADAC has been published 342 times since Mar 18, 2020.
FDA first approved this application on Dec 14, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Xiromed LLCNDC
70700012487
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA205131FDA Approved
12/14/2017
TE Code
AB
On Market Since
2/11/2019
Price Statistics
The NADAC for LOJAIMIESS 0.1-0.02-0.01 TAB has been published 342 times since Mar 18, 2020, and over the history we have for it it has declined 36.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2339 per EA |
|---|---|
| All-time high | $0.4996 (Aug 12, 2020) |
| All-time low | $0.1337 (Jul 17, 2024) |
| 52-week high | $0.2436 |
| 52-week low | $0.1911 |
| Median price | $0.2680 |
| Average price | $0.2755 |
| Largest weekly change | +86.4% (Nov 22, 2023) |
| Weeks tracked | 342 |
| Tracking since | Mar 18, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the levonorgestrel/ethinyl estradiol and ethinyl estradiol market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Xiromed LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
levonorgestrel/ethinyl estradiol and ethinyl estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LOJAIMIESS 0.1-0.02-0.01 TAB?
The current National Average Drug Acquisition Cost (NADAC) for LOJAIMIESS 0.1-0.02-0.01 TAB, manufactured by Xiromed LLC, is $0.2339 per EA (NDC 70700012487), effective Sep 30, 2026.
How has the price of LOJAIMIESS 0.1-0.02-0.01 TAB changed over time?
Over the history we have for it, the NADAC for LOJAIMIESS 0.1-0.02-0.01 TAB has declined 36.7%. It has been tracked across 342 weekly CMS publications since Mar 18, 2020.
What are the highest and lowest recorded NADAC prices for LOJAIMIESS 0.1-0.02-0.01 TAB?
Since Mar 18, 2020, the NADAC for LOJAIMIESS 0.1-0.02-0.01 TAB has ranged from a low of $0.1337 (Jul 17, 2024) to a high of $0.4996 (Aug 12, 2020), with a median of $0.2680 per EA.
Are there cheaper alternatives to LOJAIMIESS 0.1-0.02-0.01 TAB?
No other NADAC-published product currently shares the active ingredient and strength of LOJAIMIESS 0.1-0.02-0.01 TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LOJAIMIESS 0.1-0.02-0.01 TAB?
LOJAIMIESS 0.1-0.02-0.01 TAB (NDC 70700012487) is labeled by Xiromed LLC, and CMS classifies it as a generic product.